8 research outputs found
Towards a comprehensive estimate of national spending on prevention
Background
Comprehensive information about national spending on prevention is crucial for health policy development and evaluation. This study provides a comprehensive overview of prevention spending in the Netherlands, including those activities beyond the national health accounts.
Methods
National spending on health-related primary and secondary preventive activities was examined by funding source with the use of national statistics, government reports, sector reports, and data from individual health associations and corporations, public services, occupational health services, and personal prevention. Costs were broken down by diseases, age groups and gender using population-attributable risks and other key variables.
Results
Total expenditures on prevention were €12.5 billion or €769 per capita in the Netherlands in 2003, of which 20% was included in the national health accounts. 82% was spent on health protection, 16% on disease prevention, and 2% on health promotion activities. Most of the spending was aimed at the prevention of infectious diseases (34%) and acute physical injuries (29%). Per capita spending on prevention increased steeply by age.
Conclusion
Total expenditure on health-related prevention is much higher than normally reported due to the inclusion of health protection activities beyond the national health accounts. The allocative efficiency of prevention spending, particularly the high costs of health protection and the low costs of health promotion activities, should be addressed with information on their relative cost effectiveness
Voluntary disclosure of corporate strategy: determinants and outcomes. An empirical study into the risks and payoffs of communicating corporate strategy.
Business leaders increasingly face pressure from stakeholders to be transparent. There
appears however little consensus on the risks and payoffs of disclosing vital information
such as corporate strategy. To fill this gap, this study analyzes firm-specific determinants
and organisational outcomes of voluntary disclosure of corporate strategy. Stakeholder
theory and agency theory help to understand whether companies serve their interest to
engage with stakeholders and overcome information asymmetries. I connect these
theories and propose a comprehensive approach to measure voluntary disclosure of
corporate strategy. Hypotheses from the theoretical framework are empirically tested
through panel regression of data on identified determinants and outcomes and of
disclosed strategy through annual reports, corporate social responsibility reports,
corporate websites and corporate press releases by the 70 largest publicly listed
companies in the Netherlands from 2003 through 2008. I found that industry,
profitability, dual-listing status, national ranking status and listing age have significant
effects on voluntary disclosure of corporate strategy. No significant effects are found for
size, leverage and ownership concentration. On outcomes, I found that liquidity of stock
and corporate reputation are significantly influenced by voluntary disclosure of corporate
strategy. No significant effect is found for volatility of stock. My contributions to theory,
methodology and empirics offers a stepping-stone for further research into understanding
how companies can use transparency to manage stakeholder relations